dr reddy's glp-1 drugs portfolio 2025 Dr. to expand with focus on obesity and diabetes drug markets India is launching cheap weight-loss

In the Modular Medical study, the therapy elicited weight-lowering effects in the DIO mouse model, whether administered by intermittent subcutaneous injection or subcutaneous pump

Garcia JM, Boccia RV, Graham CD, Yan Y, Duus EM, Allen S, et al

The 0.01 mg/kg dose that showed consistent effects in rats translates to approximately 0.0016 to 0.004 mg/kg in humans, which works out to roughly 0.112 to 0.28 mg for a 154-pound person

Choline depletion causes hepatic steatosis within weeks even in lean individuals consuming adequate protein and calories, which underscores its non-negotiable role in hepatic lipid export

In addition to their role in weight loss, these drugs have shown promising early evidence of cardiovascular benefits in obese patients, further enhancing their clinical relevance